{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:01:13Z","timestamp":1781456473890,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,13]]},"DOI":"10.7759\/cureus.110791","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:43:48Z","timestamp":1781455428000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report"],"prefix":"10.7759","author":[{"given":"Akemini J","family":"Udoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadanar","family":"Yukyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Z","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram A","family":"Gandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fizza","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1615\/IntJMedMushrooms.2021041921","article-title":"Psilocybin conspectus: status, production methods, and considerations","volume":"24","author":"Plotnik L","year":"2022","unstructured":"Plotnik L, Gibbs G, Graham T. Psilocybin conspectus: status, production methods, and considerations. Int J Med Mushrooms. 2022, 24:1-11. 10.1615\/IntJMedMushrooms.2021041921","journal-title":"Int J Med Mushrooms"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00048","article-title":"Psilocybin therapeutic research: the present and future paradigm","volume":"11","author":"Kargbo RB","year":"2020","unstructured":"Kargbo RB. Psilocybin therapeutic research: the present and future paradigm. ACS Med Chem Lett. 2020, 11:399-402. 10.1021\/acsmedchemlett.0c00048","journal-title":"ACS Med Chem Lett"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229067","article-title":"Self-reported negative outcomes of psilocybin users: a quantitative textual analysis","volume":"15","author":"Bienemann B","year":"2020","unstructured":"Bienemann B, Ruschel NS, Campos ML, Negreiros MA, Mograbi DC. Self-reported negative outcomes of psilocybin users: a quantitative textual analysis. PLoS One. 2020, 15:e0229067. 10.1371\/journal.pone.0229067","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50612-3","article-title":"Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat","volume":"9","author":"Smigielski L","year":"2019","unstructured":"Smigielski L, Kometer M, Scheidegger M, Kr\u00e4henmann R, Huber T, Vollenweider FX. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Sci Rep. 2019, 9:14914. 10.1038\/s41598-019-50612-3","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley L","year":"2023","unstructured":"Ley L, Holze F, Arikci D, et al.. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacology. 2023, 48:1659-67. 10.1038\/s41386-023-01607-2","journal-title":"Neuropsychopharmacology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2025.2450240","article-title":"Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon","volume":"63","author":"Correia MS","year":"2025","unstructured":"Correia MS, Gonzaga MJ, Temple C, Gerona RR. Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon. Clin Toxicol (Phila). 2025, 63:261-6. 10.1080\/15563650.2025.2450240","journal-title":"Clin Toxicol (Phila)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1794811","article-title":"Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review","volume":"13","author":"Reinert JP","year":"2020","unstructured":"Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL. Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review. Expert Rev Clin Pharmacol. 2020, 13:847-56. 10.1080\/17512433.2020.1794811","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1987090","article-title":"Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?","volume":"12","author":"Gibbons WJ Jr","year":"2021","unstructured":"Gibbons WJ Jr, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA. Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?. Bioengineered. 2021, 12:8863-71. 10.1080\/21655979.2021.1987090","journal-title":"Bioengineered"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2020.08.005","article-title":"Neurotoxicology syndromes associated with drugs of abuse","volume":"38","author":"Caplan RA","year":"2020","unstructured":"Caplan RA, Zuflacht JP, Barash JA, Fehnel CR. Neurotoxicology syndromes associated with drugs of abuse. Neurol Clin. 2020, 38:983-96. 10.1016\/j.ncl.2020.08.005","journal-title":"Neurol Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12494","article-title":"Main artifacts in electrocardiography","volume":"23","author":"P\u00e9rez-Riera AR","year":"2018","unstructured":"P\u00e9rez-Riera AR, Barbosa-Barros R, Daminello-Raimundo R, de Abreu LC. Main artifacts in electrocardiography. Ann Noninvasive Electrocardiol. 2018, 23:e12494. 10.1111\/anec.12494","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2024.2368617","article-title":"Hypertensive emergency secondary to combining psilocybin mushrooms, extended release dextroamphetamine-amphetamine, and tranylcypromine","volume":"57","author":"Barnett BS","year":"2025","unstructured":"Barnett BS, Koons CJ, Van den Eynde V, Gillman PK, Bodkin JA. Hypertensive emergency secondary to combining psilocybin mushrooms, extended release dextroamphetamine-amphetamine, and tranylcypromine. J Psychoactive Drugs. 2025, 57:297-303. 10.1080\/02791072.2024.2368617","journal-title":"J Psychoactive Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454073-acute-hallucinogen-intoxication-following-ingestion-of-a-commercially-available-mushroom-extract-product-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:43:49Z","timestamp":1781455429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454073-acute-hallucinogen-intoxication-following-ingestion-of-a-commercially-available-mushroom-extract-product-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.110791","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,13]]}}}